GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $334,000 | -13.5% | 7,623 | -12.9% | 0.00% | 0.0% |
| Q1 2022 | $386,000 | -6.3% | 8,757 | -5.3% | 0.00% | 0.0% |
| Q4 2021 | $412,000 | +16.7% | 9,245 | +1.4% | 0.00% | -20.0% |
| Q3 2021 | $353,000 | +47.7% | 9,119 | +54.0% | 0.01% | +66.7% |
| Q2 2021 | $239,000 | -28.0% | 5,922 | -36.3% | 0.00% | -40.0% |
| Q1 2021 | $332,000 | -0.3% | 9,299 | +4.2% | 0.01% | 0.0% |
| Q4 2020 | $333,000 | -26.5% | 8,924 | -24.8% | 0.01% | -37.5% |
| Q3 2020 | $453,000 | -24.6% | 11,866 | -18.2% | 0.01% | -38.5% |
| Q2 2020 | $601,000 | +138.5% | 14,502 | +124.9% | 0.01% | +62.5% |
| Q1 2020 | $252,000 | -60.8% | 6,449 | -52.4% | 0.01% | -52.9% |
| Q4 2019 | $643,000 | +11.6% | 13,539 | +1.3% | 0.02% | -5.6% |
| Q3 2019 | $576,000 | +79.4% | 13,364 | +76.5% | 0.02% | +50.0% |
| Q1 2019 | $321,000 | +101.9% | 7,570 | +84.1% | 0.01% | +33.3% |
| Q4 2018 | $159,000 | – | 4,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |